CoChat

Exploratory analysis of eating-and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment

Open access

The DOI matches its Crossref record; the references it cites are not checked yet; 14 of the 35 sources its claims cite were checked for support.

Abstract

Weight regain after weight loss remains a major challenge in obesity treatment and may involve alteration of eating and sedentary behavior after weight loss. In this randomized, controlled, double-blind trial, adults with obesity were randomized, in a 1:1:1:1 ratio stratified by sex and age group (<40 years and ≥40 years), to one-year weight loss maintenance with exercise, the GLP-1 receptor agonist liraglutide, or the combination, as compared with placebo, after low-calorie diet-induced weight loss. Primary outcome was change in body weight, which has been published. Here, we investigated the effects of weight loss maintenance with exercise, liraglutide, or the combination on weight loss-induced changes in the pre-specified explorative outcomes, eating and sedentary behavior in 130 participants who completed the trial according to the study protocol (exercise (n = 26), liraglutide (n = 36), combination (n = 29), and placebo (n = 39)). One year after weight loss, the placebo group had decreased postprandial appetite suppression score by 14%, and increased sedentary time by 31 min/day and regained weight. Liraglutide prevented the decrease in postprandial appetite suppression score compared with placebo (0% vs. −14%; P = 0.023) and maintained weight loss. Exercise after weight loss did not increase appetite or sedentary behavior compared with placebo, despite increased exercise energy expenditure and maintained weight loss. The combination of exercise and liraglutide increased cognitive restraint score (13% vs. −9%; P = 0.042), reflecting a conscious restriction of food intake, and decreased sedentary time by 41 min/day (−10 vs. 31 min/day; 95%CI, −82.3 to −0.2; P = 0.049) compared with placebo, which may have facilitated the additional weight loss. Targeting both eating and sedentary behavior could be the most effective for preventing weight regain. Trial registration: EudraCT number, 2015-005585-32; clinicaltrials.gov number, NCT04122716.

Overview

CoChat Summary

TL;DR

In a one-year randomized trial after diet-induced weight loss, placebo was associated with increased appetite and sedentary time and weight regain, while liraglutide prevented the appetite increase and exercise did not further increase appetite despite higher exercise energy expenditure. Combining exercise and liraglutide improved cognitive restraint and reduced sedentary time, and this combination produced the greatest additional weight loss.

Key findings

  • In the per-protocol population (n = 130), placebo regained 6.1 kg after the initial 13.7 kg diet-induced weight loss, had a 14% decrease in postprandial appetite suppression score, and increased accelerometer-measured sedentary time by 31 min/day.
  • Liraglutide prevented the decrease in postprandial appetite suppression score (0% vs. −14%; P = 0.023) and maintained weight loss (−1.9 kg; difference from placebo, −8.0 kg; 95% CI, −11.7 to −4.2).
  • Exercise did not increase appetite or sedentary behavior compared with placebo despite increased exercise energy expenditure (1661 ± 738 kcal/week in the exercise group) and maintained weight loss (0.7 kg; difference from placebo, −5.3 kg; 95% CI, −9.4 to −1.2).
  • The combination of exercise and liraglutide increased cognitive restraint score (13% vs. −9%; P = 0.042), decreased sedentary time by 41 min/day (−10 vs. 31 min/day; 95% CI, −82.3 to −0.2; P = 0.049), and produced additional weight loss (−6.0 kg; difference from placebo, −12.1 kg; 95% CI, −16.1 to −8.1).

Methods

  • Randomized, double-blind, placebo-controlled 2-by-2 factorial trial in adults aged 18–65 years with obesity (BMI 32–43 kg/m²) without diabetes; after an 8-week ~800 kcal/day low-calorie diet, participants with ≥5% weight loss were randomized 1:1:1:1, stratified by sex and age group, to exercise + placebo, liraglutide 3.0 mg/day, combination, or placebo for one year.
  • Eating behavior was assessed with the Three-Factor Eating Questionnaire-R18; appetite with visual analog scale ratings during a 3-hour mixed meal; food preferences with the Leeds Food Preference Questionnaire; sedentary behavior and physical activity with 7-day wrist-worn accelerometry and the IPAQ-SF; exercise energy expenditure with Polar sports watches.
  • Changes were analyzed with linear mixed models including time, group, sex, age group, and time–group interaction, in per-protocol and intention-to-treat populations; multiple regression tested associations between behavioral changes and weight change, with analyses described as exploratory and unadjusted for multiplicity.

Limitations

  • The authors state they cannot prove causal inferences that the measured outcomes are the reason for the weight changes, although this seems probable.
  • The per-protocol analysis may introduce subset selection bias that cannot be distinguished from the treatment effect; intention-to-treat analyses generally showed the same picture.
  • The analyses were exploratory and unadjusted for multiplicity, so definite inferences cannot be made; additionally, wrist-worn accelerometry was not expected to detect the stationary-bike exercise, so self-reported physical activity was also used.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-022-32307-y

Cites

Statistics

Nothing to recompute.

Figures

Fig. 1 Changes in postprandial appetite suppression and eating behavior during the study. Violin plots of observed changes in a postprandial appetite suppression score, b cognitive restraint, c emotional eating, and d uncontrolled eating. Changes are from week −8 to week 0 (low-calorie diet, yellow color in grey shaded area, n = 130) for all groups combined and from week 0 to week 52 (after randomization) in the four groups, separately: placebo (grey color, n = 39), exercise (green color, n = 26), liraglutide (blue color, n = 36), and the combination of liraglutide and exercise (red color, n = 29). The diamonds indicate observed means and the dots indicate individual observations. The appetite suppression score was calculated as (satiety + fullness + [100 – hunger] + [100 – prospective food consumption])/4; all were subjective ratings (180 min area under the curve from visual analogue scales. Cognitive restraint, emotional eating, and uncontrolled eating scores were measured on a 0–100 scale by Three-Factor Eating Questionnaire-R18. Results are presented for study participants who adhered to the study interventions (per protocol population). P-values are provided for significant (P < 0.05) differences from the placebo group. P-values are two-sided and unadjusted for multiple comparisons and derived from a mixed model analysis as described in statistical analyses. Source data are provided as a Source Data file.
Fig. 1 Changes in postprandial appetite suppression and eating behavior during the study. Violin plots of observed changes in a postprandial appetite suppression score, b cognitive restraint, c emotional eating, and d uncontrolled eating. Changes are from week −8 to week 0 (low-calorie diet, yellow color in grey shaded area, n = 130) for all groups combined and from week 0 to week 52 (after randomization) in the four groups, separately: placebo (grey color, n = 39), exercise (green color, n = 26), liraglutide (blue color, n = 36), and the combination of liraglutide and exercise (red color, n = 29). The diamonds indicate observed means and the dots indicate individual observations. The appetite suppression score was calculated as (satiety + fullness + [100 – hunger] + [100 – prospective food consumption])/4; all were subjective ratings (180 min area under the curve from visual analogue scales. Cognitive restraint, emotional eating, and uncontrolled eating scores were measured on a 0–100 scale by Three-Factor Eating Questionnaire-R18. Results are presented for study participants who adhered to the study interventions (per protocol population). P-values are provided for significant (P < 0.05) differences from the placebo group. P-values are two-sided and unadjusted for multiple comparisons and derived from a mixed model analysis as described in statistical analyses. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 2 Changes in sedentary time during the study. a Mean±SEM changes in sedentary time from week −8 to week 0 (low-calorie diet, yellow color in grey shaded area, n = 130) for all groups combined and from week 0 to week 52 (after randomization) in the four groups, separately: placebo (grey color, n = 39), exercise (green color, n = 26), liraglutide (blue color, n = 36), and the combination of liraglutide and exercise (red color, n = 29). Means were estimated from a mixed model analysis as described in statistical analyses. Results are presented for study participants who adhered to the study interventions (per protocol population). Sedentary time was measured with wrist-worn accelerometry. b Violin plots of observed changes in sedentary time the low-calorie diet and for all groups, separately. The diamonds indicate observed means and the dots indicate individual observations. Results are presented for the per protocol population (n = 130). P values are provided for significant (P < 0.05) differences from the placebo group. P-values are two-sided and unadjusted for multiple comparisons and derived from a mixed model analysis as described in statistical analyses. Source data are provided as a Source Data file.
Fig. 2 Changes in sedentary time during the study. a Mean±SEM changes in sedentary time from week −8 to week 0 (low-calorie diet, yellow color in grey shaded area, n = 130) for all groups combined and from week 0 to week 52 (after randomization) in the four groups, separately: placebo (grey color, n = 39), exercise (green color, n = 26), liraglutide (blue color, n = 36), and the combination of liraglutide and exercise (red color, n = 29). Means were estimated from a mixed model analysis as described in statistical analyses. Results are presented for study participants who adhered to the study interventions (per protocol population). Sedentary time was measured with wrist-worn accelerometry. b Violin plots of observed changes in sedentary time the low-calorie diet and for all groups, separately. The diamonds indicate observed means and the dots indicate individual observations. Results are presented for the per protocol population (n = 130). P values are provided for significant (P < 0.05) differences from the placebo group. P-values are two-sided and unadjusted for multiple comparisons and derived from a mixed model analysis as described in statistical analyses. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 3 Performed exercise during the study. a Weekly energy expended during exercise (kcal/week), b weekly exercise duration (min/week), and c weekly exercise intensity (percentage of maximum heart rate) from the first week after randomization (week 1) throughout the one-year intervention period in the two groups that included an exercise intervention: exercise (green color, n = 26) and the combination of exercise and liraglutide (red color, n = 29). The exercise program consisted of a gradual increase from week 1 to 6 after which the exercise program was fully implemented. Plotted values are observed means for study participants who adhered to the study interventions (per protocol population). Source data are provided as a Source Data file.
Fig. 3 Performed exercise during the study. a Weekly energy expended during exercise (kcal/week), b weekly exercise duration (min/week), and c weekly exercise intensity (percentage of maximum heart rate) from the first week after randomization (week 1) throughout the one-year intervention period in the two groups that included an exercise intervention: exercise (green color, n = 26) and the combination of exercise and liraglutide (red color, n = 29). The exercise program consisted of a gradual increase from week 1 to 6 after which the exercise program was fully implemented. Plotted values are observed means for study participants who adhered to the study interventions (per protocol population). Source data are provided as a Source Data file.CC BY · PubMed Central

Verification

Claims the paper makes

7 Valid · 2 Not valid · 10 Not checked · 84 Own results and interpretations

56 more claims

Create a free account to see all 103 claims and to verify the 21 references still open.

See all claims — free account
  • Probably not a substantial claim. 19
  • It may state two separate claims as one. 31
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

3 of 3

Citations

The citation lists are queued

They are fetched later and appear here then.

References 45 · Cited by 42

Metadata

Authors
Jensen, S. B. K., Janus, C., Lundgren, J. R., Juhl, C. R., Sandsdal, R. M., Olsen, L. M., Andresen, A., Borg, S. A., Jacobsen, I. C., Finlayson, G., Stallknecht, B. M., Holst, J. J., Madsbad, S., & Torekov, S. S.
Affiliations
  • University of Copenhagen (DK)
  • University of Leeds (GB)
  • Hvidovre Hospital (DK)
Corresponding author
Torekov, Signe Sørensen
Venue
Nature Communications
Published
2022-08-15
Volume
13
Issue
1
Pages
4770-4770
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4291511774
Cited by
42
References
45
Citations by year
2026: 7 · 2025: 15 · 2024: 10 · 2023: 9 · 2022: 1
FWCI
5.24
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Danish Diabetes Academy
  • Novo Nordisk
  • Helsefonden
  • Faculty of Health and Medical Sciences, University of Western Australia
  • Novo Nordisk Fonden (NNF15CC0018486, NNF20SA0064144, NNF16OC0019968, NNF20SA0064145, NNF15SA0018486, NNF20SA0064142)
  • Det Sundhedsvidenskabelige Fakultet, Københavns Universitet
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
weight loss maintenance, obesity, liraglutide, GLP-1 receptor agonists, physical activity, sedentary behavior, dietary habits, postprandial appetite, cognitive restraint, weight regain, hypocaloric diet, energy expenditure
MeSH terms
Liraglutide, Adult, Double-Blind Method, Humans, Hypoglycemic Agents, Obesity, Weight Gain, Weight Loss, Exercise

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exploratory analysis of eating-and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment. https://app.cochat.ai/papers/10.1038/s41467-022-32307-y
The paper
Jensen, S. B. K., Janus, C., Lundgren, J. R., Juhl, C. R., Sandsdal, R. M., Olsen, L. M., Andresen, A., Borg, S. A., Jacobsen, I. C., Finlayson, G., Stallknecht, B. M., Holst, J. J., Madsbad, S., & Torekov, S. S. (2022). Exploratory analysis of eating-and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment. Nature Communications. https://doi.org/10.1038/s41467-022-32307-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.